Adcendo vs ONCOMATRYX
Adcendo vs ONCOMATRYX, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adcendo is on 60/100 and ONCOMATRYX on 50/100.
Where each one leads
Adcendo
- our overall score: 60/100 against 50/100
- headcount: 60 against 36
- funding raised: $272M against $107M
- LinkedIn following: 9,847 against 5,170
ONCOMATRYX
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adcendo | ONCOMATRYX |
|---|---|---|
| What it is | Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Pharmaceuticals, Oncology, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2017 | 2009 |
| Headquarters | Copenhagen, Denmark | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Adcendo | ONCOMATRYX |
|---|---|---|
| Employees | 60 | 36 |
| Total funding | $272M | $107M |
| Latest round | Series C | Funding Round |
| LinkedIn followers | 9,847 | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adcendo | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 50/100 |
| Traction | 58/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 34/100 | 37/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adcendo | ONCOMATRYX |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Adcendo vs ONCOMATRYX: common questions
Which is better, Adcendo or ONCOMATRYX?
On our 0-100 score Adcendo rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Adcendo and ONCOMATRYX compare on the numbers?
Adcendo leads on our overall score (60/100 against 50/100), headcount (60 against 36), funding raised ($272M against $107M), LinkedIn following (9,847 against 5,170).
Read the full Adcendo review and pricing or the ONCOMATRYX review and pricing. You can also browse other Adcendo alternatives we track.